Research powered investment banking
Home
Research
Companies
Find Alpha
Themes
Top Picks
Premium
Transactions
Events
Redeye
At a Glance
Our Culture
Investor Services
Corporate Broking
Certified Adviser
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
Members network
Community
sign in
Home
research
Companies
Find Alpha
Themes
Top Picks
Transactions
Events
redeye
About
At a Glance
Our Culture
Investor Services
Corporate Broking
Certified Adviser
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
Community
Company overview

Enlabs: Bid on Enlabs

Redeye Research Note timeStamp 2021/01/07

Today Entain plc, previously GVC Holdings plc, has made a public offer to acquire Enlabs at SEK 40 share, which is spot on our latest fair value of Enlabs. The bid has also been recommended by the Independent Bid Committee of Enlabs and accepted by the largest shareholders. However, we regard the bid premium as low.

Today Entain plc, previously GVC Holdings plc, has made a public offer to acquire Enlabs at SEK 40 share, which is spot on our latest fair value of Enlabs. We also saw Enlabs as a potential acquisition target, which also the market probably did as well. As a result, an acquisition was likely partly included in the share price before the bid. However, given the synergy opportunities, we expected that Entain plc would be willing to offer a more significant premium than 1%.

It should, however, be noted that the offer represents a premium of 42% compared to the volume-weighted average price during the last 180 trading days and a premium of 16% compared to the volume-weighted average price during the last 90 trading days. The Independent Bid Committee of Enlabs AB also states that the premium was 87% compared to the share price on 20 February 2020, which was the last trading day before the Board of Directors of Enlabs received the first indicative bid letter from Entain.

In conjunction with the public offering Enlabs also publishes preliminary results for the fourth quarter of 2020. The preliminary revenues came in line with our estimates, while the adjusted EBITDA came in around 14% above our estimates. Without any further details about investments in marketing etc. it is challenging to say if the result is good or not. However, based on the information we have, it would be more likely that we would increase the fair value of Enlabs than decrease it.

In conclusion

We find the bid premium somewhat low given synergy opportunities. But the offer does overall reflect the fair value of Enlabs. Furthermore, the offer has already been accepted by several larger shareholders holding shares corresponding to 42.2% of the total shares in Enlabs.

Jonas Amnesten

Jonas Amnesten

Equity Analyst

Tomas Otterbeck

Tomas Otterbeck

Equity Analyst

Tagged companies
  • Office
  • Mäster Samuelsgatan 42, 10th floor
  • Box 7141, 103 87
  • Stockholm, Sweden
  • info@redeye.se
  • +46 (0)8 545 013 30
  • Services
  • Home
  • Research
  • Transactions
  • Events
  • Redeye
  • Community
  • Members Home
  • Premium
  • Legal
  • Terms and conditions (Swedish)
  • Terms of membership (Swedish)
  • Terms and conditions - Advisory (Swedish)
  • Terms and conditions - Advisory (English)
  • Integrity Policy (Swedish)
  • Disclaimer (Swedish)
  • Governance
  • Follow
  • Twitter
  • Facebook
  • LinkedIn
  • Redeye
  • At a Glance
  • Our Culture
  • Investor Services
  • Corporate Broking
  • Corporate Finance
  • Newsroom
  • The Team
  • Careers
  • FAQ

© All rights reserved. Redeye AB is authorised and regulated by the Swedish Financial Supervisory Authority, Finansinspektionen. 2021

You need to be a Redeye member to access this content

Become a member to:

  • Access all our extensive research on 100+ Nordic Tech and Life Science companies
  • Make smarter investment decisions with the guidance of our experienced analysts
  • Receive exciting offers to participate in IPO’s and other transactions

    By clicking "Sign up" you indicate that you read and agree to our Terms & Conditions

    I already have an account and want to sign in